Using AI to Treat Infections more Accurately

New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections (UTIs), and help to address antimicrobial resistance (AMR).

AMR occurs when bacteria, viruses, fungi, and parasites evolve and no longer respond to treatments that were once effective. This resistance leads to longer hospital stays, higher medical costs, and increased mortality rates, posing a significant threat to public health and potentially rendering common infections untreatable.

Traditional UTI diagnostic tests, known as antimicrobial susceptibility testing (AST), uses a one-size-fits-all approach to determine which antibiotics are most effective against a specific bacterial or fungal infection. This new research, published in Nature Communications, proposes a personalised method, using real-time data to help clinicians target infections more accurately and reduce the chance of bacteria becoming resistant to antibiotic treatment.

The research, led by Dr Alex Howard, a consultant in medical microbiology at the University of Liverpool and researcher on the Wellcome Trust funded CAMO-Net, used AI to test prediction models for 12 antibiotics using real patient data and compared personalised AST with standard methods. The data-driven personalised approach led to more accurate treatment options, especially with WHO Access antibiotics, known for being less likely to cause resistance.

Dr Alex Howard, said: "This research is important and timely for World AMR Awareness Week because it shows how combining routine health data with lab tests can help keep antibiotics working. By using AI to predict when people with urine infections have antibiotic-resistant bugs, we show how lab tests can better direct their antibiotic treatment. This approach could improve the care of people with infections worldwide and help prevent the spread of antibiotic resistance."

The results of this study represent a significant step forward in addressing AMR. By prioritising WHO access category antibiotics and tailoring treatment to individual susceptibility profiles, the personalised AST approach not only improves the efficiency of the testing process but also supports global efforts to preserve the effectiveness of critical antibiotics.

Howard A, Hughes DM, Green PL, Velluva A, Gerada A, Maskell S, Buchan IE, Hope W.
Personalised antimicrobial susceptibility testing with clinical prediction modelling informs appropriate antibiotic use.
Nat Commun. 2024 Nov 21;15(1):9924. doi: 10.1038/s41467-024-54192-3

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...